Maryland Oncology Hematology — Columbia, Maryland

Maryland Oncology Hematology is a clinical research site located in Columbia, Maryland, United States 21044.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Maryland Oncology Hematology has participated in 13 clinical trials with 7 currently active.

Therapeutic areas: SARS-CoV-2 Infection, Primary Myelofibrosis, Myelodysplastic Syndromes.

Sponsors: MediMergent, LLC, Celgene, Ayala Pharmaceuticals, Inc,.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Maryland Oncology Hematology?

Maryland Oncology Hematology has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Maryland Oncology Hematology conducted?

Maryland Oncology Hematology has 13 clinical trials on record, with 7 currently active. Their work covers SARS-CoV-2 Infection, Primary Myelofibrosis, Myelodysplastic Syndromes.

Is Maryland Oncology Hematology accredited by Crixeo Health?

Yes — Maryland Oncology Hematology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Maryland Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.